Page 162 - Presents News Today

PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company

STOCKHOLM, Sweden, June 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Svenska Vaccinfabriken has presented results from a preclinical study indicating

LONDON (dpa-AFX) - Ionis Pharmaceuticals Inc. (IONS) announced that GSK presented positive results from an interim analysis of the Phase 2b B-Clear clinical study of bepirovirsen (formerly IONIS-HBVRx)

VS-01 Reduced Plasma Metabolites Associated with Organ Failures Related to ACLF Metabolomic analysis of organ failure markers abstract selected for inclusion in the 'Best of International

Largest multinational survey highlights impact of pruritus on quality of life for patients with primary sclerosing cholangitis Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) presented data at the

Results showed improved or preserved cognitive function in a majority of people regardless of baseline values, with the greatest effect observed in almost 80% of people with high thalamic volume (45.5%

Salt Lake City, Utah--(Newsfile Corp. - June 23, 2022) - Gaensel Energy Group, Inc., (OTC Pink: GEGR) ("Gaensel" or the "Company"), a diversified holding company, announces following corporate update.

Clinical trial interim results of SCG101 shows tumour control with lesion shrinkage observed in two out of three patients with advanced HBV-related HCCResults show rapid and significant serum

STOCKHOLM, Sweden, June 23, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Promimic today presented preclinical results tshowing that the company's HAnano

CAICV Presents Establishment Meeting of the International Communication and Cooperation Committee of ICV Roadmaps